Tonix Pharmaceuticals Announces Issuance of U.S. Patent for TNX-801 Smallpox and Monkeypox Vaccine and Recombinant Pox Virus (RPV) Platform Technology - Yahoo Finance
6/1/2022 12:00:00 AM2 years 11 months ago
by Tonix Pharmaceuticals Holding Corp.
by Tonix Pharmaceuticals Holding Corp.
Strengthens Patent Portfolio Protecting Horsepox-Based Live Virus Vaccines TNX-1840 and TNX-1850 are Potential RPV Vaccines Designed to Protect Against COVID...
Tonix Pharmaceuticals Holding Corp. Strengthens Patent Portfolio Protecting Horsepox-Based Live Virus Vaccines TNX-1840 and TNX-1850 are Potential RPV Vaccines Designed to Protect Against COVID-19 … [+12157 chars]
full article...